Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy

<div>Survival outcomes per systemic inflammation response index (SIRI) groups: (a) progression-free survival, and (b) overall survival.</div>

Gastroenterology Research and Practice

fig2

Figure 2

Figure 2: Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy 

Figure 2 | Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy 